Výsledky vyhledávání - Ugochi Emeribe
- Zobrazuji výsledky 1 - 4 z 4
-
1
Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous c... Autor Jill Gilbert, Christophe Le Tourneau, Hisham Mehanna, Jérôme Fayette, Trishna Goswami, Ugochi Emeribe, Anthony Jarkowski, Giovanni Melillo, L.L. Siu
Vydáno 2015Artigo -
2
Phase III, randomized, open-label study of durvalumab (MEDI4736) monotherapy, or durvalumab + tremelimumab, versus standard of care (SoC), in recurrent or metastatic (R/M) squamous... Autor Robert L. Ferris, C. Even, Robert Haddad, Makoto Tahara, Trishna Goswami, April Franks, Ugochi Emeribe, Anthony Jarkowski, Giovanni Melillo, Lisa Licitra
Vydáno 2015Artigo -
3
-
4
Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours Autor Stan B. Kaye, Steinar Aamdal, Richard D. Jones, Gilles Freyer, Éric Pujade-Lauraine, Elisabeth G.E. de Vries, Jorge Barriuso, Shahneen Sandhu, Daniel S.W. Tan, V Hartog, Bart C. Kuenen, Rita Ruijter, Gunnar B. Kristensen, Marta Nyakas, Sophie Barrett, Wendy Burke, D Pietersma, Melissa K. Stuart, Ugochi Emeribe, Epie Boven
Vydáno 2012Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Chemotherapy
Surgery
Basal cell
Cancer
Durvalumab
Head and neck
Immunotherapy
Ipilimumab
Nivolumab
Oncology
Tremelimumab
Adverse effect
Alternative medicine
Anesthesia
Carboplatin
Cetuximab
Cisplatin
Clinical endpoint
Colorectal cancer
Confidence interval
Engineering
Head and neck cancer
Head and neck squamous-cell carcinoma
Immune checkpoint
Immune system
Immunology
Ischemia
Ischemic stroke